Aminoglycoside-induced ototoxicity
Authors:
Open Access
- 15 September 2014
- journal article
- review article
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 187 (1) , E52
Abstract
Aminoglycosides cause toxicity of the vestibular (balance) or cochlear (hearing) systems of the inner ear in up to 10% of patients receiving these drugs intravenously.[1][1] Frequently permanent, toxicity can result in failure to return to work and diminished quality of life. Gentamicin, tobramycinKeywords
This publication has 5 references indexed in Scilit:
- Gentamicin ototoxicity: a 23‐year selected case series of 103 patientsMedical Journal of Australia, 2012
- Aminoglycoside-Induced Vestibular Injury: Maintaining a Sense of BalanceAnnals of Pharmacotherapy, 2008
- Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control teamJournal of Antimicrobial Chemotherapy, 2006
- Permanent Gentamicin VestibulotoxicityOtology & Neurotology, 2004
- Ototoxicity and topical eardropsClinical Otolaryngology, 1998